• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.

作者信息

Weissman I L

出版信息

J Natl Cancer Inst. 1973 Aug;51(2):443-8.

PMID:4765368
Abstract
摘要

相似文献

1
Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.体内肿瘤免疫：肿瘤的免疫破坏使“旁观者”细胞保持完整的证据。
J Natl Cancer Inst. 1973 Aug;51(2):443-8.
2
Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.携带不同大小同基因纤维肉瘤的C3Hf-Bu小鼠对肺转移的免疫抗性
Cancer Res. 1974 Jan;34(1):61-71.
3
Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.本地小鼠和过继性保护小鼠对自发性和化学诱导性肿瘤的免疫状态。
Cancer Res. 1972 Nov;32(11):2545-50.
4
Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.同基因肿瘤组织残留或再次注射所导致的伴随免疫和免疫特异性抑制。
Cancer Res. 1971 Nov;31(11):1655-62.
5
Normal tissue antigens of tumor cells.
Tex Rep Biol Med. 1969 Summer;27(2):467-9.
6
Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.B7转染肿瘤诱导的抗肿瘤免疫反应的特异性和持久性。
Cancer Res. 1994 Dec 15;54(24):6477-83.
7
Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
Cell Immunol. 1972 Sep;5(1):201-8.
8
The development of cellular immunity to tumor cells.对肿瘤细胞的细胞免疫的发展。
Surg Gynecol Obstet. 1972 May;134(5):739-45.
9
Effect of dietary amino acids on tumour growth and cell-mediated immune responses.膳食氨基酸对肿瘤生长及细胞介导免疫反应的影响。
Clin Invest Med. 1981;4(2):109-15.
10
Humoral and cellular immune factors in the systemic control of artifically induced metastases in C3Hf mice.C3Hf小鼠人工诱导转移的全身控制中的体液和细胞免疫因子。
Cancer Res. 1973 Aug;33(8):1957-65.

引用本文的文献

1
Mutant p53-specific CD8TCR-therapy combined with a CD4TCR prevents relapse of cancer and outgrowth of micrometastases.突变型p53特异性CD8TCR疗法联合CD4TCR可预防癌症复发和微转移灶的生长。
Oncoimmunology. 2025 Dec;14(1):2514041. doi: 10.1080/2162402X.2025.2514041. Epub 2025 Jun 14.
2
Evolution of normal and neoplastic tissue stem cells: progress after Robert Hooke.正常组织和肿瘤组织干细胞的演化：罗伯特·胡克之后的进展
Philos Trans R Soc Lond B Biol Sci. 2015 Oct 19;370(1680):20140364. doi: 10.1098/rstb.2014.0364.
3
IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.
在已建立的小鼠癌症中，γ干扰素和肿瘤坏死因子依赖的旁观者对抗原缺失变体的清除作用
J Clin Invest. 2008 Apr;118(4):1398-404. doi: 10.1172/JCI33522.
4
Mice coisogenically immunized against H-2 class I antigens on transfected L cells reject transplanted embryonal carcinoma cells.在转染的L细胞上针对H-2 I类抗原进行同基因免疫的小鼠会排斥移植的胚胎癌细胞。
Immunogenetics. 1985;22(6):533-41. doi: 10.1007/BF00430301.
5
The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. II. Lyt-1+2- T cells have potential to reject antigenically irrelevant (bystander) tumor cells on activation with the specific target tumor cells.肿瘤特异性Lyt-1+2- T细胞在体内清除肿瘤细胞中的作用。II. Lyt-1+2- T细胞在与特异性靶肿瘤细胞激活后有潜力排斥抗原无关（旁观者）肿瘤细胞。
Cancer Immunol Immunother. 1987;24(1):8-12. doi: 10.1007/BF00199826.